Alibaba Health Information Technology Limited

Alibaba Health Information Technology Limited

TWY · STU · Healthcare / Pharmaceutical Retailers

0.3157EUR-0.00 (-1.34%)

Price History

Full chart

Market Stats

Previous Close0.32
Open0.32
Day Range0.3147 – 0.3242
52-Week Range0.1691 – 0.8012
Volume27.90K
Market Cap5.18B
P/E (TTM)32.00
Forward P/E18.32
EPS0.01
Dividend Yield2.33%
Beta1.58
50-Day Avg0.3484
200-Day Avg0.4721

About

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, health food, adult and family planning products, healthcare and skincare products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, appointment-booking, vaccination, dental care, mental care, optometry, and nursing services, as well as traditional Chinese medicines. The company provides is products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Ele.me, AMap, DingTalk, Freshippo, and Quark. In addition, it engages in the digital tracking business; provision of network hospital, software technical services, healthcare related internet information and technical services; operation of internet hospitals, as well as Doctor U, an intelligent and one-stop platform for doctor and patient education; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Yong Yu
  • Employees1.44K
  • HeadquartersTower One, Causeway Bay, Hong Kong, Germany
  • Websitehttps://www.alihealth.cn

Leadership

  • Mr. Difan ShenExecutive Director · b. 1978
  • Mr. Yong YuCEO & Executive Chairman · b. 1976
  • Ms. Mengyue ShengCFO & Executive Director · b. 1982
  • Ms. Deng YanChief Legal Advisor & Joint Company Secretary
  • Ms. Yin RuiChief Marketing Officer
  • Ms. Zhang HuaChief People Officer
  • Mr. Chun Chung KwongFinancial Controller
  • Ms. Hiu Leong TsuiLegal Counsel & Joint Company Secretary

Financials

Income Statement

Currency: CNY2017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Revenue475.08M2.44B5.10B9.60B15.52B20.58B26.76B27.03B30.60B34.26B
Growth (%)-+414.15%+108.62%+88.32%+61.71%+32.60%+30.06%+0.98%+13.22%+11.95%
Cost of Revenue287.83M1.79B3.76B7.37B11.90B16.47B21.06B21.13B23.17B26.05B
Gross Profit187.24M652.82M1.33B2.23B3.62B4.11B5.70B5.90B7.43B8.21B
Gross Margin39.41%26.73%26.12%23.25%23.31%19.96%21.30%21.81%24.29%23.97%
Operating Expense385.18M782.00M1.42B2.27B3.51B5.13B5.65B5.18B5.86B6.32B
Operating Income-197.94M-129.18M-93.33M-42.15M110.83M-1.02B51.25M712.26M1.58B1.89B
Operating Margin-41.66%-5.29%-1.83%-0.44%0.71%-4.95%0.19%2.64%5.15%5.52%
EBITDA--80.51M-28.88M72.75M403.67M-248.70M620.55M999.05M1.62B2.33B
EBITDA Margin--3.30%-0.57%0.76%2.60%-1.21%2.32%3.70%5.30%6.80%
Net Income-207.63M-106.97M-81.95M-6.59M348.59M-265.56M535.65M883.48M1.43B1.94B
Net Income Margin-43.70%-4.38%-1.61%-0.07%2.25%-1.29%2.00%3.27%4.68%5.65%
R&D108.58M126.22M219.02M252.84M423.63M728.83M677.82M705.38M720.05M788.35M
R&D as % of Total Revenue22.86%5.17%4.30%2.63%2.73%3.54%2.53%2.61%2.35%2.30%
Interest Expense0027.97M21.96M2.45M3.81M5.83M5.97M2.61M1.40M
Interest Expense % of Total Revenue0.00%0.00%0.55%0.23%0.02%0.02%0.02%0.02%0.01%0.00%

Balance Sheet

Currency: CNY2017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Assets1.68B3.11B5.98B7.87B17.74B19.20B20.75B19.71B21.18B23.09B
Total Liabilities560.04M587.92M3.25B2.67B3.46B5.13B5.60B5.19B4.87B5.24B
Total Equity1.18B2.58B2.79B5.27B14.30B14.10B15.17B14.54B16.31B17.86B
Cash569.86M508.42M280.37M2.59B11.64B10.55B10.92B9.55B2.22B5.43B
Net Debt--1.42B-------

Cash Flow

Currency: CNY2017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Operating Cash Flow-226.25M-70.27M396.37M583.62M1.01B424.36M255.69M1.08B1.40B1.24B
Investing Cash Flow-158.75M-1.21B-2.40B1.35B-4.96B1.87B----
Financing Cash Flow192.85M1.25B1.71B328.81M8.92B-58.63M----
Capital Expenditure2.14M5.73M6.10M7.57M17.08M14.93M5.92M22.78M18.90M8.99M
Free Cash Flow--76.00M390.27M570.10M1.01B424.36M255.69M1.06B1.38B1.23B
FCF to OCF-108.16%98.46%97.68%100.00%100.00%100.00%97.89%98.64%99.27%

Key Statistics & Ratios

Market Cap5.18B
Enterprise Value3.79B
Trailing P/E32.00
Forward P/E18.32
PEG Ratio0.69
Price / Sales0.15
Price / Book2.15
EPS0.01
Book Value0.1366
Revenue (TTM)34.26B
Gross Profit (TTM)8.21B
EBITDA1.86B
Profit Margin5.65%
Operating Margin4.05%
Return on Equity11.33%
Return on Assets5.16%
Shares Outstanding16.18B
Shares Float5.87B
Beta1.58
Dividend Yield2.33%
Dividend Rate0.01
Payout Ratio0.00%

Dividends

20261×
0.03Aug 12, 2026